Dr. Anthony Anzell, Cure HHT’s newest recipient of the Compassionate Champion award, Board Member, Researcher and HHT patient is gearing up for another one of his, as he likes to call it, “Crazy Events.” Anthony and five of his friends, have created their bigger version of the Ironman competition with an Ultra-Tri, taking place August…Learn More >>
Cure HHT recognizes centers equipped with the personnel, expertise, commitment, and resources to provide comprehensive evaluation, treatment, and education to individuals with HHT and their families. After 18 months of training, mentor center communications and a site visit from Cure HHT’s Center of Excellence (COE) Committee, Barrow Neurological Institute is named the 30th HHT CoE in North…Learn More >>
Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome, is an inherited disease that leads to malformed blood vessels in multiple organs of the body and typically begins with nosebleeds during childhood. HHT can result in serious health problems if not promptly diagnosed and treated. Our mission is to find a cure for HHT while saving the lives and improving the well-being of individuals and families affected by HHT.